Chimeric antigen receptor T-cell (CAR-T) therapy provided to Medicare Advantage (MA) beneficiaries will be paid for by traditional Medicare for calendar years 2019 and 2020.
This week’s Medicare updates include the October edition of the Medicare Quarterly Compliance Newsletter, a pair of requests for information on potential usage of artificial intelligence to prevent fraud, Medicare Advantage billing instructions for CAR-T therapy, and more!
To prepare for natural disasters such as hurricanes, community case managers must reach out to and support their patients who are elderly, disabled, or otherwise at risk. Disaster preparation is a huge endeavor for case managers.
